| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fdedf00ffcf8f1f82a10647131abc8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012cf8b9ee234f16ade05b4175a1efee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae08443cd2c0fde77ca82a29a9c67154 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f3cc5be0bf7d97ed2f26a6b2598aac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_261a6e922d53d0b442d570b4525cb132 |
| publicationDate |
2011-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011305741-A1 |
| titleOfInvention |
Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis |
| abstract |
A composition comprising a synthetic growth factor analogue comprising a non-growth factor heparin binding region, a linker and a sequence that binds specifically to a cell surface receptor and an osteoconductive material where the synthetic growth factor analogue is attached to and can be released from the osteoconductive material and is an amplifier/co-activator of osteoinduction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10207030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47115-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014123978-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10174088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3162374-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10611810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889235-B2 |
| priorityDate |
2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |